Viral Vector Purification Market Soars to $3.98 Billion by 2030

The viral vector purification market is experiencing rapid growth due to increasing demand for high-quality viral vectors and advancements in gene therapy and bioprocessing. According to a recent report, the market is expected to reach $3.98 billion by 2030 with a compound annual growth rate (CAGR) of 17.8% during the forecast period.

The growth can be attributed to several factors including higher demand for clinical-grade viral vectors, increased investments in downstream bioprocessing, expansion of gene therapy pipelines, and adoption of automated purification platforms. Additionally, stringent regulatory requirements surrounding product purity are also driving market expansion.

The report highlights the importance of high-resolution chromatography, scalable purification technologies, single-use systems, enhanced vector isolation techniques, and process yield optimization in shaping the future of the industry. Key players such as Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, and Danaher Corporation are leading the market with their innovative solutions.